The new analgesic combination tramadol/acetaminophen.

T Schnitzer
{"title":"The new analgesic combination tramadol/acetaminophen.","authors":"T Schnitzer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Combinations of analgesic drugs provide the opportunity for better efficacy with less overall morbidity than provided by single analgesic agents. This article discusses the rationale, efficacy and safety for a novel analgesic combination: tramadol and acetaminophen (paracetamol).</p><p><strong>Methods: </strong>Data supporting the rationale of combining tramadol and acetaminophen to provide pain relief will be reviewed in addition to clinical data demonstrating the efficacy and safety of this combination in acute and chronic pain states.</p><p><strong>Results: </strong>Tramadol and acetaminophen are a rational combination product in that their mechanisms of action do not overlap and that in preclinical studies this combination acts synergistically. Also, this combination would be expected to provide more rapid pain relief than tramadol alone, and more persistent pain relief than acetaminophen alone. Moreover, each compound is broken down along separate metabolic pathways. Acute dental pain studies showed that pain relief and improvements in pain intensity associated with tramadol 75 mg plus acetaminophen 650 mg are superior to placebo, or tramadol or acetaminophen alone. This combination provided a rapid onset of action, identical to that achieved with acetaminophen alone, but the pain relief was also sustained, as for tramadol alone. Tramadol/acetaminophen also had the same adverse event profile as tramadol monotherapy. A chronic low back/osteoarthritic pain study showed that the drug combination can also be used similarly to codeine/acetaminophen combinations in treating benign chronic pain. The safety profile of the tramadol/ acetaminophen combination is at least as favourable as that of codeine/acetaminophen, and is well tolerated with long-term use.</p><p><strong>Conclusions: </strong>Tramadol/acetaminophen combination is a new preparation that is effective in acute or chronic moderate-to-moderately severe pain. It benefits from the complementary actions of the constituent analgesics, having the rapid onset of acetaminophen and the sustained effect of tramadol. The analgesic efficacy of this combination is comparable to that of positive controls, and its adverse event profile is in line with that of its single components.</p>","PeriodicalId":11873,"journal":{"name":"European journal of anaesthesiology. Supplement","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of anaesthesiology. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Combinations of analgesic drugs provide the opportunity for better efficacy with less overall morbidity than provided by single analgesic agents. This article discusses the rationale, efficacy and safety for a novel analgesic combination: tramadol and acetaminophen (paracetamol).

Methods: Data supporting the rationale of combining tramadol and acetaminophen to provide pain relief will be reviewed in addition to clinical data demonstrating the efficacy and safety of this combination in acute and chronic pain states.

Results: Tramadol and acetaminophen are a rational combination product in that their mechanisms of action do not overlap and that in preclinical studies this combination acts synergistically. Also, this combination would be expected to provide more rapid pain relief than tramadol alone, and more persistent pain relief than acetaminophen alone. Moreover, each compound is broken down along separate metabolic pathways. Acute dental pain studies showed that pain relief and improvements in pain intensity associated with tramadol 75 mg plus acetaminophen 650 mg are superior to placebo, or tramadol or acetaminophen alone. This combination provided a rapid onset of action, identical to that achieved with acetaminophen alone, but the pain relief was also sustained, as for tramadol alone. Tramadol/acetaminophen also had the same adverse event profile as tramadol monotherapy. A chronic low back/osteoarthritic pain study showed that the drug combination can also be used similarly to codeine/acetaminophen combinations in treating benign chronic pain. The safety profile of the tramadol/ acetaminophen combination is at least as favourable as that of codeine/acetaminophen, and is well tolerated with long-term use.

Conclusions: Tramadol/acetaminophen combination is a new preparation that is effective in acute or chronic moderate-to-moderately severe pain. It benefits from the complementary actions of the constituent analgesics, having the rapid onset of acetaminophen and the sustained effect of tramadol. The analgesic efficacy of this combination is comparable to that of positive controls, and its adverse event profile is in line with that of its single components.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新型镇痛药曲马多/对乙酰氨基酚联用。
背景:与单一镇痛药相比,联合使用镇痛药可获得更好的疗效,且总发病率更低。本文讨论了一种新型镇痛药组合曲马多和对乙酰氨基酚(扑热息痛)的原理、疗效和安全性。方法:将回顾支持曲马多联合对乙酰氨基酚缓解疼痛的基本原理的数据,以及证明该组合在急性和慢性疼痛状态下的有效性和安全性的临床数据。结果:曲马多和对乙酰氨基酚的作用机制不重叠,在临床前研究中具有协同作用,是一种合理的联合用药。此外,这种组合将比单独曲马多提供更快速的疼痛缓解,比单独对乙酰氨基酚更持久的疼痛缓解。此外,每种化合物都是通过不同的代谢途径分解的。急性牙痛研究表明,曲马多75毫克加对乙酰氨基酚650毫克与疼痛缓解和疼痛强度改善相关,优于安慰剂,或单独曲马多或对乙酰氨基酚。这种组合提供了快速的作用,与单独使用对乙酰氨基酚相同,但疼痛缓解也持续,就像单独使用曲马多一样。曲马多/对乙酰氨基酚与曲马多单药治疗也有相同的不良事件。一项慢性腰痛/骨关节炎研究表明,该药物组合也可以类似于可待因/对乙酰氨基酚组合用于治疗良性慢性疼痛。曲马多/对乙酰氨基酚联用的安全性至少与可待因/对乙酰氨基酚一样好,并且长期使用耐受性良好。结论:曲马多/对乙酰氨基酚联用是一种治疗急性或慢性中重度疼痛的新型制剂。它受益于镇痛药成分的互补作用,具有对乙酰氨基酚的快速起效和曲马多的持续作用。该组合的镇痛效果与阳性对照相当,其不良事件概况与其单一组分一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Near-infrared spectroscopy (NIRS) in a piglet model: readings are influenced by the colour of the cover Clinical sedation and bispectral index in burn children receiving gamma-hydroxybutyrate. Acute Normovolemic hemodilution during CABG induces diastolic dysfunction: A perioperative transesophageal echocardiographic study EuroNeuro 2010. Abstracts of the 6th EuroNeuro Congress. Porto, Portugal. February 4-6, 2010. 5th EuroNeuro 2008. Maastricht, The Netherlands. January 16-19, 2008. Abstracts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1